4//SEC Filing
T2 Biosystems, Inc. 4
Accession 0001104659-15-077363
CIK 0001492674operating
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 6:29 PM ET
Size
5.2 KB
Accession
0001104659-15-077363
Insider Transaction Report
Form 4
Harding David
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2015-10-30+146,600→ 146,600 totalExercise: $11.12Exp: 2015-10-30→ Common Stock (146,600 underlying)
Footnotes (1)
- [F1]25% of the total shares vest on 10/30/2016, and the remaining shares vest in substantially equal monthly installments over the following 36 months, to be fully vested on 10/30/2019.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001492674
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 6:29 PM ET
- Size
- 5.2 KB